You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alloHSCT

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 19, 2023

Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

Recruiting
  • Hematologic Diseases
  • Neoplasms
  • CD7 CAR-T cells injection
  • Allogeneic hematopoietic stem cell transplantation
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Apr 11, 2023

CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

Recruiting
  • CAR
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2022

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022

MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

Recruiting
  • MDS and Allogeneic Stem Cell Transplantation
  • MDS and AlloHSCT
  • Perugia, PG, Italy
    University of Perugia
Mar 11, 2021

Acute Myeloid Leukemia (AML) Trial in Israel, Italy (Busulphan plus Cyclophosphamide, Busulphan plus Fludarabine)

Completed
  • Acute Myeloid Leukemia (AML)
  • Busulphan plus Cyclophosphamide
  • Busulphan plus Fludarabine
  • Tel Hashomer, Israel
  • +25 more
Aug 19, 2021

ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

Active, not recruiting
  • ALL
  • Badalona, Spain
  • +9 more
Feb 17, 2022

Clinical and Biological Factors Determining Outcomes in Chronic

Recruiting
  • Chronic Graft vs Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • TCM allogeneic humane central memory T cells, cryopreserved
    • Wurzburg, Germany
      University Hospital Wuerzburg - Department of Medicine II
    Jul 12, 2022

    Acute Lymphoblastic Leukemia Trial in Spain (Pediatric-type of chemo, allogeneic HSCT)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Pediatric-type of chemotherapy
    • allogeneic HSCT
    • Badalona, Barcelona, Spain
    • +107 more
    Feb 17, 2022

    Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Aug 16, 2022

    B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

    Not yet recruiting
    • B Precursor Acute Lymphoblastic Leukemia
    • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
    • (no location specified)
    Sep 25, 2023

    Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

    Recruiting
    • Chronic GVHD
    • Bethesda, Maryland
    • +1 more
    Jan 26, 2023

    Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

    Recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • Rituximab
    • +6 more
    • Bethesda, Maryland
    • +1 more
    Aug 20, 2022

    Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

    Not yet recruiting
    • X-linked Adrenoleukodystrophy
    • brainQuant module of brainTale-care platform
    • (no location specified)
    Jun 12, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 10, 2023

    Acute Myeloid Leukemia (AML) Relapse Trial in Freiburg, Münster (F16IL2, BI 836858)

    Completed
    • Acute Myeloid Leukemia (AML) Relapse
    • Freiburg, Germany
    • +1 more
    Apr 13, 2022

    Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

    Active, not recruiting
    • Multiple Myeloma
    • +4 more
    • Total Body Irradiation
    • +5 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 21, 2022

    Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • CD33KO-HSPC; CART33
    • (no location specified)
    Jul 13, 2023

    Leukemia Trial (Prehabilitation)

    Not yet recruiting
    • Leukemia
    • Prehabilitation
    • (no location specified)
    Dec 5, 2022

    ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

    Active, not recruiting
    • ALL, Recurrent, Adult
    • Frankfurt (Main), Hessen, Germany
    • +21 more
    Mar 16, 2022

    Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial

    Not yet recruiting
    • Acute Myeloid Leukaemia (AML)
    • +2 more
    • (no location specified)
    Sep 6, 2022

    Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)

    Recruiting
    • Cytomegalovirus Infections
    • Primary Immune Deficiency Disorder
    • viral specific cytotoxic t-lymphocytes
    • Los Angeles, California
    • +7 more
    Sep 27, 2022

    Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

    Recruiting
    • Secondary Myelodysplastic Syndrome
    • Therapy-Related Myelodysplastic Syndrome
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 1, 2022

    Endocrine, Bone And Metabolic Disorders In Adults After

    Completed
    • Endocrine System Diseases
    • +3 more
      • Brest, France
        CHRU de Brest - Endocrinology and Diabetology Department
      Sep 10, 2020